Mar 6, 2025 05:19AM
May 29, 2024 04:01PM
Mar 19, 2024 08:45AM
Mar 19, 2024 08:44AM
Mar 1, 2024 08:00AM
May 31, 2023 08:00AM
Dec 22, 2022 03:34PM Today's most important downgrades
Jun 3, 2022 08:00AM
Jun 3, 2022 08:00AM
Nov 11, 2021 08:00AM
Nov 11, 2021 08:00AM
May 25, 2021 04:01PM
May 25, 2021 04:01PM
Apr 26, 2021 08:31AM Jefferies Assumes Fate Therapeutics (FATE) at Buy, 'We Predict (+) NK Data in May, More at ASCO'
Jan 8, 2021 04:26PM
Jan 8, 2021 04:26PM
Jan 6, 2021 06:10AM
Jan 6, 2021 12:30AM
Jan 6, 2021 12:30AM
Jan 4, 2021 04:02PM
Jan 4, 2021 04:01PM Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
Jan 4, 2021 04:01PM
Sep 30, 2020 08:00AM
Jun 11, 2020 04:01PM
Jun 11, 2020 04:01PM
Jun 9, 2020 05:53AM
Jun 9, 2020 12:49AM
Jun 9, 2020 12:49AM Fate Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 8, 2020 04:03PM
Jun 8, 2020 04:01PM
Jun 8, 2020 04:01PM
Nov 14, 2019 04:01PM
Nov 14, 2019 04:01PM
Sep 18, 2019 04:01PM
Sep 18, 2019 04:01PM Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 12, 2019 05:54AM
Sep 12, 2019 12:53AM
Sep 12, 2019 12:53AM
Sep 11, 2019 04:02PM
Sep 11, 2019 04:01PM
Sep 11, 2019 04:01PM
May 30, 2019 04:05PM Fate Therapeutics to Present at the Jefferies 2019 Healthcare Conference
May 30, 2019 04:05PM
Nov 8, 2018 04:01PM
Nov 8, 2018 04:01PM
Nov 5, 2018 04:32AM
Sep 25, 2018 04:01PM
Sep 25, 2018 04:01PM
Sep 21, 2018 05:48AM Fate Therapeutics (FATE) Prices 9.26M Share Common Offering at $13.50/Sh
Sep 20, 2018 11:37PM

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All